Victoria Johnson

Associate Editor at CGTLive

Reporting on cell and gene therapies for @CGT_Live 🧬| @Rutgersnb Class of 2020 🎓 [email protected] 📧 | Tweets my own ✍️ 🇵🇭

Articles

Steven W. Pipe, MD, on Evaluating siRNA Therapy Fitusiran in Combination With Antithrombin Modulation for Hemophilia

Dec 11, 2024 | cgtlive.com | Steven W Pipe |Victoria Johnson

This interview originally appeared on our sister site, HCPLive®. "Fitusiran is a highly effective prophylactic agent. The modulation of thrombin generation allows us to achieve effective bleed control with substantially lower doses of factor and bypassing agents, as well as fewer infusions.
SC291 CAR T-Cell Therapy Fast Tracked for Relapsed/Refractory SLE

Dec 3, 2024 | cgtlive.com | Victoria Johnson

A version of this article first appeared on our sister site, HCPLive.
Exploring CAR-T for Autoimmune Disease

Nov 25, 2024 | cgtlive.com | Georg Schett |Noah Stansfield |Victoria Johnson

At the American College of Rheumatology (ACR) Convergence 2024 in Washington, DC, Georg Schett, MD, vice president research and chair of internal medicine at the University of Erlangen – Nuremberg, presented data from 2 studies evaluating CD19-directed chimeric antigen receptor T-cell (CAR-T) therapies in patients with a variety of refractory autoimmune and rheumatic diseases.
Georg Schett, MD, on Exploring CAR-T for Autoimmune Disease

Nov 20, 2024 | cgtlive.com | Georg Schett |Victoria Johnson

This interview originally appeared on our sister site, HCPLive®. “The relapse rate is very low, and there have been occasional relapses reported in the field by other studies, but also with low dose CAR T-cell therapy, because that was the starting dose.
Cell Therapies Hope to be Next Frontier for Alzheimer Disease

Oct 6, 2024 | cgtlive.com | Victoria Johnson

Alzheimer disease (AD) is a growing problem, affecting nearly 7 million people in the United States. In 2021, AD was the fifth-leading cause of death among people aged 65 years and older.1 Prior to 2023, the field of research for AD had stood relatively stagnant for 10 years until the FDA approved the controversial anti-amyloid therapy aducanumab (Aduhelm).
Dupilumab Improves Sleep, Itch, and Other QoL Measures in Children With Eczema

Oct 4, 2024 | hcplive.com | Victoria Johnson

Dupilumab improved symptoms of atopic dermatitis (AD) and quality of life (QoL) in pediatric patients and their caregivers/families.1“Many symptoms (eg, pruritus, sleep disturbance) are difficult for clinicians to assess.2 Patient reported outcomes (PROs) provide an important complement to clinician-reported outcomes.
Ultrasound Detects Active Enthesitis, Synovitis While in Remission from PsA

Aug 16, 2024 | newsbreak.com | Victoria Johnson
Ultrasound Detects Active Enthesitis, Synovitis While in Remission from PsA

Aug 16, 2024 | hcplive.com | Victoria Johnson

August 16, 2024Around 20% of participants had ultrasound evidence of at least 1 active enthesitis, and 15.7% had ultrasound signs of at least 1 active synovitis at examination. A new study has found that ultrasound detects non-negligible instances of active enthesitis and synovitis in patients with psoriatic arthritis (PsA) thought to be within the therapeutic target.1“Synovitis and enthesitis can exist subclinically, indicating the existence of inflammation which can only be detected by imaging.
Insulin Resistance Associated With Higher Risk of Gout in Adults

Aug 16, 2024 | newsbreak.com | Victoria Johnson

By signing up for our newsletter, you agree to our Terms of Use and Privacy PolicyIt’s essential to note our commitment to transparency: Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies.
Insulin Resistance Associated With Higher Risk of Gout in Adults

Aug 16, 2024 | hcplive.com | Victoria Johnson

New research has found that higher triglyceride glycemic (TyG) index was associated with an increased likelihood of gout in adults in the United States.1“To the best of our knowledge, this is the first study on the association between the TyG index and gout based on the large sample size of the NHANES database. Therefore, this study contributes to the literature.